| dc.contributor.author | Langer, Robert S | |
| dc.contributor.author | Jaklenec, Ana | |
| dc.contributor.author | Traverso, Carlo Giovanni | |
| dc.contributor.author | Hartman, Daniel | |
| dc.date.accessioned | 2021-11-30T16:41:52Z | |
| dc.date.available | 2021-10-27T20:35:58Z | |
| dc.date.available | 2021-11-30T16:41:52Z | |
| dc.date.issued | 2020 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/136560.2 | |
| dc.language.iso | en | |
| dc.publisher | Wiley | en_US |
| dc.relation.isversionof | http://dx.doi.org/10.1002/CPT.1676 | en_US |
| dc.rights | Creative Commons Attribution 4.0 International license | en_US |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US |
| dc.source | Wiley | en_US |
| dc.title | From Molecule to Patient: A Biotech Perspective | en_US |
| dc.type | Article | en_US |
| dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Mechanical Engineering | en_US |
| dc.relation.journal | Clinical Pharmacology and Therapeutics | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dc.date.updated | 2021-06-22T14:12:14Z | |
| dspace.orderedauthors | Langer, R; Jaklenec, A; Traverso, G; Hartman, D | en_US |
| dspace.date.submission | 2021-06-22T14:12:17Z | |
| mit.journal.volume | 107 | en_US |
| mit.journal.issue | 1 | en_US |
| mit.license | PUBLISHER_CC | |
| mit.metadata.status | Publication Information Needed | en_US |
